Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
9.12
+0.14 (1.56%)
At close: Mar 9, 2026, 4:00 PM EDT
10.75
+1.63 (17.87%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Zevra Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 62.41 | 33.79 | 43.05 | 65.47 | 112.35 | Upgrade
|
| Short-Term Investments | 128.61 | 35.71 | 24.69 | 17.38 | - | Upgrade
|
| Cash & Short-Term Investments | 191.01 | 69.5 | 67.74 | 82.85 | 112.35 | Upgrade
|
| Cash Growth | 174.85% | 2.60% | -18.24% | -26.26% | 2566.65% | Upgrade
|
| Accounts Receivable | 23.26 | 10.18 | 16.12 | 7.19 | 1.42 | Upgrade
|
| Other Receivables | - | 0.33 | 1.26 | 1.11 | 0.11 | Upgrade
|
| Receivables | 23.26 | 10.51 | 17.38 | 8.3 | 1.53 | Upgrade
|
| Inventory | 1.74 | 1.97 | - | - | - | Upgrade
|
| Prepaid Expenses | 7 | 4.05 | 1.82 | 1.69 | 0.89 | Upgrade
|
| Other Current Assets | - | - | - | - | 0.29 | Upgrade
|
| Total Current Assets | 223.01 | 86.03 | 86.94 | 92.83 | 115.06 | Upgrade
|
| Property, Plant & Equipment | 1.7 | 1.01 | 1.53 | 1.78 | 2.03 | Upgrade
|
| Long-Term Investments | 47.88 | 6.01 | - | 20 | 15.42 | Upgrade
|
| Goodwill | 4.7 | 4.7 | 4.7 | - | - | Upgrade
|
| Other Intangible Assets | 6.42 | 68.99 | 69.23 | - | - | Upgrade
|
| Other Long-Term Assets | 1.02 | 11.38 | 9.94 | 0.72 | 0.44 | Upgrade
|
| Total Assets | 284.73 | 178.13 | 172.33 | 115.34 | 132.94 | Upgrade
|
| Accounts Payable | 11.6 | 13.08 | 13.99 | 3.61 | 0.52 | Upgrade
|
| Accrued Expenses | 12.19 | 17.37 | 18.97 | 7.21 | 2.52 | Upgrade
|
| Short-Term Debt | - | - | 37.7 | - | - | Upgrade
|
| Current Portion of Leases | 0.42 | 0.42 | 0.54 | 0.49 | 0.37 | Upgrade
|
| Current Income Taxes Payable | 13.71 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 1.36 | 3.2 | 2.52 | 0.71 | 0.82 | Upgrade
|
| Total Current Liabilities | 39.28 | 34.07 | 73.72 | 12.02 | 4.23 | Upgrade
|
| Long-Term Debt | 61.93 | 59.5 | 5.07 | 12.8 | - | Upgrade
|
| Long-Term Leases | 0.86 | 0.37 | 0.46 | 0.84 | 1.24 | Upgrade
|
| Other Long-Term Liabilities | 28.01 | 44.52 | 31.22 | 14.55 | 0.36 | Upgrade
|
| Total Liabilities | 130.07 | 138.46 | 110.46 | 40.22 | 5.82 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 588.46 | 555.3 | 472.66 | 436.27 | 396.96 | Upgrade
|
| Retained Earnings | -422.06 | -505.29 | -399.78 | -353.73 | -267.03 | Upgrade
|
| Treasury Stock | -10.98 | -10.98 | -10.98 | -7.54 | -2.81 | Upgrade
|
| Comprehensive Income & Other | -0.76 | 0.63 | -0.04 | 0.11 | - | Upgrade
|
| Shareholders' Equity | 154.66 | 39.67 | 61.86 | 75.12 | 127.12 | Upgrade
|
| Total Liabilities & Equity | 284.73 | 178.13 | 172.33 | 115.34 | 132.94 | Upgrade
|
| Total Debt | 63.21 | 60.3 | 43.77 | 14.13 | 1.61 | Upgrade
|
| Net Cash (Debt) | 127.81 | 9.2 | 23.97 | 68.72 | 110.74 | Upgrade
|
| Net Cash Growth | 1289.18% | -61.62% | -65.11% | -37.95% | - | Upgrade
|
| Net Cash Per Share | 2.23 | 0.20 | 0.68 | 1.99 | 3.72 | Upgrade
|
| Filing Date Shares Outstanding | 58.71 | 54.12 | 41.85 | 34.54 | 34.42 | Upgrade
|
| Total Common Shares Outstanding | 56.85 | 53.67 | 41.53 | 34.54 | 35.01 | Upgrade
|
| Working Capital | 183.73 | 51.96 | 13.22 | 80.81 | 110.83 | Upgrade
|
| Book Value Per Share | 2.72 | 0.74 | 1.49 | 2.17 | 3.63 | Upgrade
|
| Tangible Book Value | 143.54 | -34.03 | -12.06 | 75.12 | 127.12 | Upgrade
|
| Tangible Book Value Per Share | 2.52 | -0.63 | -0.29 | 2.17 | 3.63 | Upgrade
|
| Machinery | - | 1.36 | 1.51 | 1.28 | 1.05 | Upgrade
|
| Leasehold Improvements | - | 0.71 | 0.71 | 0.71 | 0.72 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.